Victor Dillard
2017, Europe
AI for designing safe and effective genome editing therapies
Biotechnology

With a background in chemical engineering and bioscience enterprise, 28 year-old Victor Dillard has wasted no time in transforming his passion for genomics and personalized medicine into his own company: Desktop Genetics.

This firm, at which Dillard currently serves as COO and CFO, has developed an AI that enables the design and production of safe and effective genome editing therapies, personalised to the genome of the cells to be edited.

Thanks to their tools, scientists and doctors could now be able to design safe and effective personalized genome editing therapies for use in pre-clinical research and clinical cell therapy, based on the actual DNA sequence of the patient.